arrow_right
Case Studies & Presentations
Case Studies and Presentations
Learn from your peers how they’ve integrated Percepta GSC into their clinical practice.
Percepta GSC Case Study

Dr Jonathan Kurman provides an overview of the Percepta GSC test and shares a real-world case study where the Percepta GSC test helped re-stratify a patient with an intermediate pre-test ROM to low ROM post Percepta GSC testing.

Percepta GSC Overview and Integration in Clinical Practice
Dr Chakravarthy Reddy, Associate Professor, University of Utah School of Medicine, shares an overview of the Percepta Genomic Sequencing Classifier to stratify the risk of lung cancer when bronchoscopy is inconclusive and how to integrate this test into clinical practice.
Percepta GSC and Envisia Classifier Case Study

Dr. Nina Maouelainin shares a case where Percepta GSC up-classified the risk of lung cancer guiding the next intervention step, and Envisia determined a UIP pattern to improve ILD diagnostic confidence, guiding management using a non-invasive bronchoscopy.

Percepta GSC Physician Testimonial
Hear from Dr. Nina Maouelainin on how she integrated Percepta GSC into her clinical practice and the test’s impact on patient management.
Improving Diagnostic Confidence for Lung Nodule Diagnosis
Dr. Kyle Hogarth reviews how Percepta GSC works and how to integrate the test into patient management.
CHEST 2021 Percepta Portfolio Lung Cancer Presentation
Drs Jonathan Kurman & Bill Bulman discuss gaps in lung nodule management, early lung cancer diagnosis, and the transformative role novel genomic tests play in lung nodule management and the lung cancer care continuum.
Percepta GSC Down-Classification Case Study
Dr. Krish Bhadra shares a case where Percepta GSC down-classified the risk and changed patient management.
Percepta GSC Down-Classification Case Study
Dr. Andres Yepes shares a case where Percepta GSC down-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, saving the patient from an
unnecessary invasive procedure.
Percepta GSC Up-Classification Case Study
Dr. Andres Yepes shares a clinical case where Percepta GSC up-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, informing the next intervention steps.
  • Percepta GSC Case Study

    Dr Jonathan Kurman provides an overview of the Percepta GSC test and shares a real-world case study where the Percepta GSC test helped re-stratify a patient with an intermediate pre-test ROM to low ROM post Percepta GSC testing.

  • Percepta GSC Overview and Integration in Clinical Practice
    Dr Chakravarthy Reddy, Associate Professor, University of Utah School of Medicine, shares an overview of the Percepta Genomic Sequencing Classifier to stratify the risk of lung cancer when bronchoscopy is inconclusive and how to integrate this test into clinical practice.
  • Percepta GSC and Envisia Classifier Case Study

    Dr. Nina Maouelainin shares a case where Percepta GSC up-classified the risk of lung cancer guiding the next intervention step, and Envisia determined a UIP pattern to improve ILD diagnostic confidence, guiding management using a non-invasive bronchoscopy.

  • Percepta GSC Physician Testimonial
    Hear from Dr. Nina Maouelainin on how she integrated Percepta GSC into her clinical practice and the test’s impact on patient management.
  • Improving Diagnostic Confidence for Lung Nodule Diagnosis
    Dr. Kyle Hogarth reviews how Percepta GSC works and how to integrate the test into patient management.
  • CHEST 2021 Percepta Portfolio Lung Cancer Presentation
    Drs Jonathan Kurman & Bill Bulman discuss gaps in lung nodule management, early lung cancer diagnosis, and the transformative role novel genomic tests play in lung nodule management and the lung cancer care continuum.
  • Percepta GSC Down-Classification Case Study
    Dr. Krish Bhadra shares a case where Percepta GSC down-classified the risk and changed patient management.
  • Percepta GSC Down-Classification Case Study
    Dr. Andres Yepes shares a case where Percepta GSC down-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, saving the patient from an
    unnecessary invasive procedure.
  • Percepta GSC Up-Classification Case Study
    Dr. Andres Yepes shares a clinical case where Percepta GSC up-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, informing the next intervention steps.
The Percepta GSC stratifies the risk of primary lung cancer to guide
patient management when bronchoscopy is inconclusive.

When risk is down-classified, patients may avoid invasive procedures and when risk is up-classified, it can inform next intervention steps.
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name*
Last Name*
Email*
Institution/Practice*
Zip Code*
Which Test Interests You?*
More About You*
Message
CONTACT REP
© 2021 Veracyte, Inc. All rights reserved.